Grant, Marshall http://orcid.org/0000-0002-0022-6873
Heise, Tim http://orcid.org/0000-0002-8346-2037
Baughman, Robert http://orcid.org/0000-0003-2752-9855
Clinical trials referenced in this document:
Documents that mention this clinical trial
Comparison of Pharmacokinetics and Pharmacodynamics of Inhaled Technosphere Insulin and Subcutaneous Insulin Lispro in the Treatment of Type 1 Diabetes Mellitus
https://doi.org/10.1007/s40262-021-01084-0
Funding for this research was provided by:
mannkind corporation
Article History
Accepted: 9 October 2021
First Online: 13 November 2021
Declarations
:
: This study was funded by Sanofi. Medical writing and editorial assistance were funded by MannKind Corporation.
: MG is a paid employee of MannKind Corporation and may hold stock and stock options with the company and is listed as an inventor on several MannKind Corporation patents. TH has received research funds from Adocia, Afon Technology, AstraZeneca, Biocon, Boehringer Ingelheim, Eli Lilly, Gan Lee Pharmaceuticals, Johnson&Johnson, Julphar, Mylan, Nestlé, Neuraly, Nordic Bioscience, Novo Nordisk, Sanofi, and Zealand Pharma and has received speaker honoraria and travel grants from Eli Lilly and Novo Nordisk; he is also a member of advisory panels for Novo Nordisk and Valbiotis. RB is on several MannKind Corporation patents.
: The study was approved by the Independent Ethics Committee (Ärztekammer Nordrhein) and the Bundesinstitut für Arzneimittel und Medizinprodukte (Federal [German] Institute for Drugs and Medical Products).
: Informed consent was obtained prior to the conduct of any study-related procedures.
: Consent to publish anonymized data was obtained as part of the informed consent.
: The data sets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: All authors contributed to the design, conduct/data collection, analysis, and writing of the manuscript and approve the manuscript for publication.